SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY

OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.

Subsidie
€ 3.276.577
2025

Projectdetails

Introduction

Treatment decisions for many pathological conditions, including inflammatory, degenerative, autoimmune, infectious diseases, and cancer, are largely based on microscopy study of the surgically excised tissue specimens (histology).

New Paradigm

OPTIPATH provides a new paradigm for gathering objective optical tissue-dependent data, which is essential to overcoming the diagnostic challenges of inter-observer variability and limited sensitivity and specificity.

Features of OPTIPATH

OPTIPATH will offer non-destructive, label-free, real-time, 3D presentation of tissue samples. This is enabled by:

  1. Revolutionary nano-photonic optical metasurfaces (OMS) for simultaneous single-shot acquisition of spectral and polarimetric information.
  2. Adaptive OMS actuated by thin-film piezoelectric Micro-Electro-Mechanical-Systems (MEMS) for rapid Vector Vortex Beam (VVB) shaping of light.
  3. Rapid confocal 3D imaging.

Data Interpretation

The wealth of objective diagnostic data provided will be interpreted using Machine Learning (ML) / Deep Learning (DL), and is essential to overcome inter-observer variability in diagnosis and provide actionable insights to the clinician.

Benefits

By utilizing optical markers present in unprepared tissue, histological procedures can be dramatically sped up, offering real-time diagnosis in operation theatres and pathology departments.

Conclusion

By offering timely and accurate diagnosis, OPTIPATH will enable early diagnosis and improved prognosis of recovery.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.276.577
Totale projectbegroting€ 3.276.577

Tijdlijn

Startdatum1-2-2025
Einddatum31-1-2028
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • SINTEF ASpenvoerder
  • SYDDANSK UNIVERSITET
  • OULUN YLIOPISTO
  • ASTON UNIVERSITY
  • NIL TECHNOLOGY APS
  • UNIVERSITETET I OSLO
  • OSLO UNIVERSITETSSYKEHUS HF

Land(en)

NorwayDenmarkFinlandUnited Kingdom

Inhoudsopgave

EIC Pathfinder

Financiering tot €3–4 mln voor high‑risk, high‑gain onderzoek naar baanbrekende technologieën binnen Horizon Europe.

Bekijk regeling

Vergelijkbare projecten binnen EIC Pathfinder

ProjectRegelingBedragJaarActie

MULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENT

MULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care.

EIC Pathfinder€ 2.863.733
2024
Details

ulTRafast hOlograPHic FTIR microscopY

TROPHY combines advanced microscopy techniques to enable rapid, high-resolution imaging of tumor biopsies for precise diagnosis and tailored cancer therapies, enhancing patient outcomes.

EIC Pathfinder€ 1.904.544
2022
Details

Breaking the penetration limit of microscopy – Photoswitching Optoacoustics

SWOPT aims to revolutionize in vivo imaging by combining optoacoustic imaging and photoswitching to visualize individual cells deep within tissues, enhancing research in life sciences and biomedicine.

EIC Pathfinder€ 3.536.935
2022
Details

On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology

DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.

EIC Pathfinder€ 3.018.312
2022
Details

Hybrid endoscope for esophageal in vivo histology and histochemistry

ESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment.

EIC Pathfinder€ 3.046.127
2025
Details
EIC Pathfinder

MULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENT

MULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care.

EIC Pathfinder
€ 2.863.733
2024
Details
EIC Pathfinder

ulTRafast hOlograPHic FTIR microscopY

TROPHY combines advanced microscopy techniques to enable rapid, high-resolution imaging of tumor biopsies for precise diagnosis and tailored cancer therapies, enhancing patient outcomes.

EIC Pathfinder
€ 1.904.544
2022
Details
EIC Pathfinder

Breaking the penetration limit of microscopy – Photoswitching Optoacoustics

SWOPT aims to revolutionize in vivo imaging by combining optoacoustic imaging and photoswitching to visualize individual cells deep within tissues, enhancing research in life sciences and biomedicine.

EIC Pathfinder
€ 3.536.935
2022
Details
EIC Pathfinder

On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology

DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.

EIC Pathfinder
€ 3.018.312
2022
Details
EIC Pathfinder

Hybrid endoscope for esophageal in vivo histology and histochemistry

ESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment.

EIC Pathfinder
€ 3.046.127
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Enabling the transition to 3D digital pathology

3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.

EIC Transition€ 2.493.683
2025
Details

Optical imaging platform for high-throughput longitudinal studies of the eye in disease models

The OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use.

ERC Proof of...€ 150.000
2023
Details

Chemometric histopathology via coherent Raman imaging for precision medicine

The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.

EIC Transition€ 2.441.979
2022
Details

In vivo Immunofluorescence-Optical Coherence Tomography

Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.

ERC Advanced...€ 2.500.000
2025
Details

Live imaging module for organoids

The LiveOrg project aims to develop and disseminate a non-invasive, high-resolution imaging system for organoids to enhance quality control and therapeutic evaluation across multiple medical fields.

ERC Proof of...€ 150.000
2024
Details
EIC Transition

Enabling the transition to 3D digital pathology

3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.

EIC Transition
€ 2.493.683
2025
Details
ERC Proof of...

Optical imaging platform for high-throughput longitudinal studies of the eye in disease models

The OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use.

ERC Proof of Concept
€ 150.000
2023
Details
EIC Transition

Chemometric histopathology via coherent Raman imaging for precision medicine

The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.

EIC Transition
€ 2.441.979
2022
Details
ERC Advanced...

In vivo Immunofluorescence-Optical Coherence Tomography

Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.

ERC Advanced Grant
€ 2.500.000
2025
Details
ERC Proof of...

Live imaging module for organoids

The LiveOrg project aims to develop and disseminate a non-invasive, high-resolution imaging system for organoids to enhance quality control and therapeutic evaluation across multiple medical fields.

ERC Proof of Concept
€ 150.000
2024
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.